| Urothelial Carcinoma altered in cohorts of …ALTERED_INderived200 of 408show all (up to 200) |
|---|
| ← altered in cohorts of | CDH1 27 / 34 cases (79 %) · ssm · blca_plasmacytoid_mskcc_2016 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN2B 267 / 412 cases (65 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTAP 261 / 412 cases (63 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | UBR5 259 / 412 cases (63 %) · ssm · TCGA-BLCA · largest of 4 cohorts | — | — | Bladder Urothelial Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | DMRTA1 255 / 412 cases (62 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRHL2 255 / 412 cases (62 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COL14A1 253 / 412 cases (61 %) · ssm · TCGA-BLCA · largest of 4 cohorts | — | — | Bladder Urothelial Carcinoma | 4 | Observed | gdc | graph → |
| ← altered in cohorts of | MYOM2 253 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PABPC1 253 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TEX15 253 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF10A 253 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF706 253 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADRA1A 252 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RIMS2 252 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDCA2 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO43 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NEFM 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RNF19A 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SORBS3 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YWHAZ 251 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ANKRD46 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLC1 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NCALD 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRG1 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIWIL2 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP3CC 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRAG1 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSD3 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RGS22 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RP1L1 250 / 412 cases (61 %) · ssm · TCGA-BLCA · largest of 2 cohorts | — | — | Bladder Urothelial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | RRM2B 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SH2D4A 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPAG1 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF10C 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF10D 250 / 412 cases (61 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EGR3 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LGI3 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LOXL2 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LZTS1 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFHAS1 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NEFL 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NPM2 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC39A14 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNX31 249 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGEF10 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAH1 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BMP1 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C8orf58 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCAR2 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHMP7 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DMTN 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOCK5 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENTPD4 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM160B2 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FGL1 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HR 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | INTS10 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLF10 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PDLIM2 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PNMA2 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLR2K 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POLR3D 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | REEP4 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RHOBTB2 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | STC1 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XPO7 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF596 248 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADAM28 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP6V1B2 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BIN3 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DEFB103A 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DOK2 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DPYS 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO25 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GFRA2 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNRH1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LONRF1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LPL 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MCPH1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MTUS1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NKX3-1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ODF1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCM1 247 / 412 cases (60 %) · ssm · TCGA-BLCA · largest of 2 cohorts | — | — | Bladder Urothelial Carcinoma | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | R3HCC1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCARA3 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SGCZ 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC18A1 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TNFRSF10B 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | VIRMA 247 / 412 cases (60 %) · ssm · TCGA-BLCA | — | — | Bladder Urothelial Carcinoma | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 245 / 474 cases (52 %) · ssm · blca_msk_tcga_2020 · largest of 21 cohorts | — | — | Bladder Urothelial Carcinoma | 21 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 155 / 474 cases (33 %) · ssm · blca_msk_tcga_2020 · largest of 10 cohorts | — | — | Bladder Urothelial Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 139 / 474 cases (29 %) · ssm · blca_msk_tcga_2020 · largest of 16 cohorts | — | — | Bladder Urothelial Carcinoma | 16 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 127 / 474 cases (27 %) · ssm · blca_msk_tcga_2020 · largest of 15 cohorts | — | — | Bladder Urothelial Carcinoma | 15 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KDM6A 124 / 474 cases (26 %) · ssm · blca_msk_tcga_2020 · largest of 17 cohorts | — | — | Bladder Urothelial Carcinoma | 17 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDC1 21 / 90 cases (23 %) · ssm · blca_pdx_msk_2025 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 103 / 474 cases (22 %) · ssm · blca_msk_tcga_2020 · largest of 14 cohorts | — | — | Bladder Urothelial Carcinoma | 14 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 101 / 474 cases (21 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TERT 101 / 474 cases (21 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RB1 100 / 474 cases (21 %) · ssm · blca_msk_tcga_2020 · largest of 9 cohorts | — | — | Bladder Urothelial Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 44 / 242 cases (18 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 80 / 474 cases (17 %) · ssm · blca_msk_tcga_2020 · largest of 12 cohorts | — | — | Bladder Urothelial Carcinoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC5AC 39 / 242 cases (16 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC3A 38 / 242 cases (16 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WIZ 38 / 242 cases (16 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP300 70 / 474 cases (15 %) · ssm · blca_msk_tcga_2020 · largest of 9 cohorts | — | — | Bladder Urothelial Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB2 70 / 474 cases (15 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IRF2BPL 35 / 242 cases (14 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 66 / 474 cases (14 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB3 65 / 474 cases (14 %) · ssm · blca_msk_tcga_2020 · largest of 8 cohorts | — | — | Bladder Urothelial Carcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FSIP2 33 / 242 cases (14 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HELZ2 33 / 242 cases (14 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KIAA1549 26 / 192 cases (14 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR2 64 / 474 cases (14 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FANCA 25 / 192 cases (13 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KNL1 25 / 192 cases (13 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RECQL4 25 / 192 cases (13 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH6 31 / 242 cases (13 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PHLDA1 31 / 242 cases (13 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FGFR3 60 / 474 cases (13 %) · ssm · blca_msk_tcga_2020 · largest of 14 cohorts | — | — | Bladder Urothelial Carcinoma | 14 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LAMA5 30 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAML3 30 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 58 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 8 cohorts | — | — | Bladder Urothelial Carcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 58 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CR1 29 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PHLPP1 29 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIM48 29 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BIRC6 56 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CREBBP 56 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 9 cohorts | — | — | Bladder Urothelial Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HMCN1 55 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAG2 55 / 474 cases (12 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH23 28 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FNDC1 28 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCOA3 28 / 242 cases (12 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CNTRL 22 / 192 cases (11 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRIP11 22 / 192 cases (11 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 54 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FLG 53 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2A 53 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRRCC1 27 / 242 cases (11 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RPS3A 27 / 242 cases (11 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT4 52 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CEP350 26 / 242 cases (11 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX3 26 / 242 cases (11 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERCC2 50 / 474 cases (11 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CLTCL1 20 / 192 cases (10 %) · ssm · blca_bcan_hcrn_2022 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARHGAP5 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH14 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNHD1 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBAS 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIEZO2 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PXDN 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TYW1 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UNC80 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF469 25 / 242 cases (10 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 48 / 474 cases (10 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ELF3 48 / 474 cases (10 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHR 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CMYA5 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EYS 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGA 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYO15A 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PDZD2 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRB 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SP8 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 24 / 242 cases (9.9 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA2 47 / 474 cases (9.9 %) · ssm · blca_msk_tcga_2020 · largest of 7 cohorts | — | — | Bladder Urothelial Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | OBSCN 47 / 474 cases (9.9 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CUBN 46 / 474 cases (9.7 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD17 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD62 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARHGEF17 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL5A3 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSPG4 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM186A 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LTBP1 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NBEA 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NCOR2 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 · largest of 2 cohorts | — | — | Bladder Urothelial Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PLXNB2 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF292 23 / 242 cases (9.5 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 45 / 474 cases (9.5 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AKAP9 44 / 474 cases (9.3 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 44 / 474 cases (9.3 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX4 44 / 474 cases (9.3 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASPM 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CEP192 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC2H1 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GREB1 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAST4 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH4 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRRC2C 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RBM4 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RP1 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPTBN4 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TENM2 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TRPS1 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDR97 22 / 242 cases (9.1 %) · ssm · blca_iatlas_imvigor210_2017 | — | — | Bladder Urothelial Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANK2 43 / 474 cases (9.1 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 42 / 474 cases (8.9 %) · ssm · blca_msk_tcga_2020 · largest of 5 cohorts | — | — | Bladder Urothelial Carcinoma | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDKN1A 42 / 474 cases (8.9 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |